王胜军, 王玉梅, 李国生. 过敏性鼻炎-哮喘综合征患儿血清IL-17A sST2与病情控制的相关性[J]. 河北医学, 2025, 31(1): 100-106.
WANG Shengjun, WANG Yumei, LI Guosheng. Correlation between Serum IL-17A sST2 with Disease Control in Children with Combined Allergic Rhinitis and Asthma Syndrome. HeBei Med, 2025, 31(1): 100-106.
[1] Mao ZD,Liu ZG,Qian Y,et al.RNA sequencing and bioinformatics analysis to reveal potential biomarkers in patients with combined allergic rhinitis and asthma syndrome[J].Inflamm Res,2023,16(1):6211-6225. [2] Penaranda A,Gantiva M,Moreno-Lopez S,et al.Factors associated with allergic rhinitis and combined allergic rhinitis and asthma syndrome (CARAS) in children aged 5-18 years undergoing immunotherapy in a tropical low- or middle-income country[J].Allergol Immunopathol (Madr),2023,51(1):126-132. [3] Sun L,Wang L,Moore BB,et al.IL-17:balancing protective immunity and pathogenesis[J].Immunol Res,2023,12(1):1-7. [4] Quan J,Wen X,Su G,et al.Epithelial SIRT6 governs IL-17A pathogenicity and drives allergic airway inflammation and remodeling[J].Nat Commun,2023,14(1):8525-8536. [5] 吴勇,徐小鸿,曾丽霞.过敏性鼻炎患儿血清sST2水平及其与病情严重程度及粉尘螨滴剂治疗反应性的相关性[J].广西医学,2023,45(15):1807-1811. [6] Cavalcanti RFP,Gadelha FAAF,Paiva Ferreira LKD,et al.Limosilactobacillus fermentum modulates the gut-airway axis by improving the immune response through FOXP3 activation on combined allergic rhinitis and asthma syndrome (CARAS)[J].Immunobiology,2023,228(5):1-15. [7] Wang WW,Yu HW,Zhang B,et al.Interleukin-17A up-regulates thymic stromal lymphopoietin production by nasal fibroblasts from patients with allergic rhinitis[J].Eur Arch Otorhinolaryngol,2021,278(1):127-133. [8] Hong Y,Chu Z,Kong J,et al.IL-17A aggravates asthma-induced intestinal immune injury by promoting neutrophil trafficking[J].Leukoc Biol,2022,112(3):425-435. [9] Han X,Jin F,Liu H,et al.The effect of genetic variation and mRNA expression of interleukin-17A gene on susceptibility to asthma[J].Cell Mol Biol (Noisy-le-grand),2023,69(11):195-199. [10] Gao S,Yu L,Zhang J,et al.Expression and clinical significance of VCAM-1,IL-6,and IL-17A in patients with allergic rhinitis[J].Ann Palliat Med,2021,10(4):4516-4522. [11] Song J,Zhang H,Tong Y,et al.Molecular mechanism of interleukin-17A regulating airway epithelial cell ferroptosis based on allergic asthma airway inflammation[J].Redox Biol,2023,68(1):1-9. [12] Homsak E,Gruson D.Soluble ST2:A complex and diverse role in several diseases[J].Clin Chim Acta,2020,507(1):75-87. [13] Singh H,Khurana A,Kumar A,et al.Serum levels of interleukin-33,soluble ST2 and IgE in patients with asthma:a case-control study[J].Asthma,2024,61(1):48-57. [14] Zhu K,Xia C,Chen J,et al.Serum soluble ST2 correlated with symptom severity and clinical response of sublingual immunotherapy for house dust mite-induced allergic rhinitis patients[J].Mediators Inflamm,2021,30(1):1-12.
2025, Vol. 31 
冀公网安备13080202000677号